Literature DB >> 24835364

Challenges of biobanking in South Africa to facilitate indigenous research in an environment burdened with human immunodeficiency virus, tuberculosis, and emerging noncommunicable diseases.

Akin Abayomi1, Alan Christoffels, Ravnit Grewal, Locunda A Karam, Catherine Rossouw, Ciara Staunton, Carmen Swanepoel, Beverley van Rooyen.   

Abstract

The high burden of infectious diseases and the growing problem of noncommunicable and metabolic disease syndromes in South Africa (SA) forces a more focused research approach to facilitate cutting-edge scientific growth and public health development. Increased SA research on these diseases and syndromes and the collection of associated biospecimens has ensured a plethora of biobanks created by individuals, albeit without the foresight of prospective and collective use by other local and international researchers. As the need for access to high-quality specimens in statistically relevant numbers has increased, so has the necessity for the development of national human biobanks in SA and across the Continent. The prospects of achieving sustainable centralized biobanks are still an emerging and evolving concept, primarily and recently driven by the launch of the H3Africa consortium, which includes the development of harmonized and standardized biobanking operating procedures. This process is hindered by a myriad of complex societal considerations and ethico-legal challenges. Efforts to consolidate and standardize biological sample collections are further compromised by the lack of full appreciation by national stakeholders of the biological value inherent in these collections, and the availability of high quality human samples with well-annotated data for future scientific research and development. Inadequate or nonexistent legislative structures that specifically regulate the storage, use, dispersal, and disposal of human biological samples are common phenomena and pose further challenges. Furthermore, concerns relating to consent for unspecified future uses, as well as access to information and data protection, are all new paradigms that require further consideration and public engagement. This article reviews important fundamental issues such as governance, ethics, infrastructure, and bioinformatics that are important foundational prerequisites for the establishment and evolution of successful human biobanking in South Africa.

Entities:  

Mesh:

Year:  2013        PMID: 24835364      PMCID: PMC4076990          DOI: 10.1089/bio.2013.0049

Source DB:  PubMed          Journal:  Biopreserv Biobank        ISSN: 1947-5543            Impact factor:   2.300


  19 in total

1.  International ethical guidelines for biomedical research involving human subjects.

Authors: 
Journal:  Bull Med Ethics       Date:  2002-10

Review 2.  Biobanking: international norms.

Authors:  Bartha Maria Knoppers
Journal:  J Law Med Ethics       Date:  2005       Impact factor: 1.718

3.  Informed consent in biobank research: a deliberative approach to the debate.

Authors:  David M Secko; Nina Preto; Simon Niemeyer; Michael M Burgess
Journal:  Soc Sci Med       Date:  2008-12-16       Impact factor: 4.634

Review 4.  Ethics of human genetic studies in sub-saharan Africa: the case of Cameroon through a bibliometric analysis.

Authors:  Ambroise Wonkam; Marcel Azabji Kenfack; Walinjom F T Muna; Odile Ouwe-Missi-Oukem-Boyer
Journal:  Dev World Bioeth       Date:  2011-07-22       Impact factor: 2.294

5.  Increases in adult life expectancy in rural South Africa: valuing the scale-up of HIV treatment.

Authors:  Jacob Bor; Abraham J Herbst; Marie-Louise Newell; Till Bärnighausen
Journal:  Science       Date:  2013-02-22       Impact factor: 47.728

6.  A review of international biobanks and networks: success factors and key benchmarks.

Authors:  Jim Vaught; Andrea Kelly; Robert Hewitt
Journal:  Biopreserv Biobank       Date:  2010-03-17       Impact factor: 2.300

7.  Trends in ethical and legal frameworks for the use of human biobanks.

Authors:  A Cambon-Thomsen; E Rial-Sebbag; B M Knoppers
Journal:  Eur Respir J       Date:  2007-08       Impact factor: 16.671

8.  Incorporating exclusion clauses into informed consent for biobanking.

Authors:  Zubin Master; David B Resnik
Journal:  Camb Q Healthc Ethics       Date:  2013-04       Impact factor: 1.284

9.  Partial relief from the regulatory vacuum involving human tissues through enactment of chapter 8 of the National Health Act and regulations thereto.

Authors:  Michael S Pepper
Journal:  S Afr Med J       Date:  2012-06-28

10.  Three-year's changes in glucose tolerance status in the Bellville South cohort: rates and phenotypes associated with progression.

Authors:  T E Matsha; D J Soita; M S Hassan; G M Hon; Y Y Yako; A P Kengne; R T Erasmus
Journal:  Diabetes Res Clin Pract       Date:  2012-11-27       Impact factor: 5.602

View more
  18 in total

Review 1.  The DISCUSS Project: Revised Points to Consider for the Derivation of Induced Pluripotent Stem Cell Lines From Previously Collected Research Specimens.

Authors:  Geoffrey P Lomax; Sara Chandros Hull; Rosario Isasi
Journal:  Stem Cells Transl Med       Date:  2015-01-05       Impact factor: 6.940

Review 2.  Opportunities and Risks for Research Biobanks in the COVID-19 Era and Beyond.

Authors:  Daniel Simeon-Dubach; Marianne K Henderson
Journal:  Biopreserv Biobank       Date:  2020-10-08       Impact factor: 2.300

3.  Online Training as a Means to Improve the Understanding of Ethical, Legal, and Social Aspects of Biobanking Research: Stakeholder Perspectives from South Africa.

Authors:  Shenuka Singh; Keymanthri Moodley; Rosemary Jean Cadigan
Journal:  Biopreserv Biobank       Date:  2021-12-20       Impact factor: 2.256

4.  Establishment of biobank facility at Endocrinology and Metabolism Research Institute of Iran: experiences, challenges, and future outlook.

Authors:  Somayeh Parichehreh-Dizaji; Hilda Samimi; Effat Asadolahpour; Farzaneh Karimi-Birgani; Vahid Haghpanah; Bagher Larijani
Journal:  J Diabetes Metab Disord       Date:  2021-04-05

5.  Challenges to biobanking in LMICs during COVID-19: time to reconceptualise research ethics guidance for pandemics and public health emergencies?

Authors:  Shenuka Singh; Rosemary Jean Cadigan; Keymanthri Moodley
Journal:  J Med Ethics       Date:  2021-05-12       Impact factor: 5.926

6.  A call for global governance of biobanks.

Authors:  Haidan Chen; Tikki Pang
Journal:  Bull World Health Organ       Date:  2014-11-24       Impact factor: 9.408

7.  Genomic research in Zambia: confronting the ethics, policy and regulatory frontiers in the 21st Century.

Authors:  Pascalina Chanda-Kapata; Nathan Kapata; Albertina Ngomah Moraes; Gershom Chongwe; James Munthali
Journal:  Health Res Policy Syst       Date:  2015-10-29

8.  "It's all about trust": reflections of researchers on the complexity and controversy surrounding biobanking in South Africa.

Authors:  Keymanthri Moodley; Shenuka Singh
Journal:  BMC Med Ethics       Date:  2016-10-10       Impact factor: 2.652

9.  Stakeholder perspectives on the ethico-legal dimensions of biobanking in South Africa.

Authors:  Shenuka Singh; Keymanthri Moodley
Journal:  BMC Med Ethics       Date:  2021-07-01       Impact factor: 2.652

10.  "The keeping is the problem": A qualitative study of IRB-member perspectives in Botswana on the collection, use, and storage of human biological samples for research.

Authors:  Francis Barchi; Keikantse Matlhagela; Nicola Jones; Poloko M Kebaabetswe; Jon F Merz
Journal:  BMC Med Ethics       Date:  2015-08-19       Impact factor: 2.652

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.